Novartis AG
Novartis AG
Novartis AG
NVS
NVS
NYSE
Health Technology
Pharmaceuticals: Major
158.15
USD
-1.83
-1.14%
Open: 08-26 15:20 (UTC+0)

NVS Key Statistics

High
159.19
Open
158.41
Volume
349.95K
Low
157.69
Prev. Close
159.98
Trading Value
55.43M
52-Week High
170.46
Relative Volume
0.261
Amplitude (%)
0.94%
52-Week Low
121.57
Turnover Rate
0.02%
Market Cap
300.59B
P/E Ratio (TTM)
--
P/E Ratio (Annual)
22.189
P/B Ratio
4.2
P/S Ratio
6.11
Earnings Per Share (EPS)
--
Dividend (TTM)
3.408
Dividend Yield
--
Shares Outstanding
2.03B
Currency Unit
USD

NVS Price Performance

7 day
30 day
90 day
180 day
Year to date
1 Year
NVS Money Flow Distribution
NVS Daily Short Sale Volume
NVS Short Interest History
As of 2026-08-26, the Novartis AG (NVS) stock price today is 158.15. Based on this price, the company has a market capitalization of $300.59B, with a P/E ratio of --. On 2026-08-26, NVS traded between 157.69 and 159.19. Today’s stock price is 0.29% above the daily low and 0.65% below the daily high, placing NVS in the lower range of its most recent trading range. Trading volume currently stands at 349.95K, compared with an average daily volume of 1.34M. This suggests that trading activity is significantly below its usual level than usual. Over the past year, Novartis AG shares have traded between 121.57 and 170.46. At today’s price, NVS is 30.09% above its 52-week low and 7.22% below its 52-week high.
Company Name
Novartis AG
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchanges
NYSE
Number of Employees
75,267
Lot Size
100
Official Website
Currency Unit
USD
Novartis AG (NVS) is a pharmaceutical company that develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.

NVS FAQ